February 2020 - Veritas Pharma Inc

Veritas Pharma Announces Preliminary Clinical Trial Results and the Company’s New Direction

by Sam Eskandari | Feb 13, 2020 | News

VANCOUVER, British Columbia, February 13, 2020 – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces its preliminary human study results of its lead cannabis treatment for acute pain, CTL-X, as well as, the...

The Veritas Newsletter

Enter your email to receive news alerts and updates from Veritas Pharma.

Veritas Pharma Announces Preliminary Clinical Trial Results and the Company’s New Direction

Categories

Archives

The Veritas Newsletter

You have Successfully Subscribed!